Et Tu, B12? Cobalamin Deficiency Masquerading As Pseudo-Thrombotic Microangiopathy.
| Autor: | Rao S; Internal Medicine, MacNeal Hospital, Berwyn, USA., Colon Hidalgo D; Internal Medicine, MacNeal Hospital, Berwyn, USA., Doria Medina Sanchez JA; Nephrology, Los Angeles County+USC Medical Center, Los Angeles, USA., Navarrete D; Internal Medicine, MacNeal Hospital, Berwyn, USA., Berg S; Hematology and Oncology, Loyola University Medical Center, Maywood, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2020 Jul 09; Vol. 12 (7), pp. e9097. Date of Electronic Publication: 2020 Jul 09. |
| DOI: | 10.7759/cureus.9097 |
| Abstrakt: | Vitamin B12 deficiency is classically associated with megaloblastic anemia. Possible cobalamin deficiency is not investigated once hemolysis is seen. Around 2.5% of cases can present as pseudo-thrombotic microangiopathy (TMA). A swift identification of this means the difference between an easy solution and a protracted one for the patient. A 74-year-old man with no past medical history presented with exertional dyspnea, fatigue, and increasing anorexia over two weeks. Physical examination including a neurological examination was normal. Laboratory tests revealed pancytopenia, unconjugated hyperbilirubinemia, elevated LDH (lactate dehydrogenase), low haptoglobin, and fragmented red blood cells (RBCs) on the peripheral smear, but normal FDP (fibrinogen degradation product) and fibrinogen. The absolute reticulocyte count was reduced as opposed to the expected elevation. Vitamin B12 levels were undetectable, and severe cobalamin deficiency from pernicious anemia was found to be the paramount etiology. Cobalamin deficiency causing pseudo-TMA baffles most physicians. Advanced pernicious anemia is thought to cause intramedullary hemolysis, resulting in peripheral pancytopenia. The fragile RBCs are easily sheared, producing schistocytosis without platelet microthrombi. In contrast to hemolytic anemias, reticulocyte count is low given the unavailability of B12 for erythropoiesis. Reticulocytopenia is a universal finding in cases of pseudo-TMA. Around 38.8% of cases with pseudo-TMA are misdiagnosed as thrombotic thrombocytopenic purpura and treated with plasma product therapy. Keeping an eye out for reticulocytopenia in cases of hemolysis could mean a world of difference for the patient. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2020, Rao et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|